October 23-24, 2014 | San Francisco, CA
www.cbinet.com/eprior
As more patients become insured due to healthcare reform, many questions arise around how to best select health plans based on personal health needs, patient eligibility, coverage benefits and out-of-pocket projections. Delays in the benefit investigation/verification process and subsequent submission of paper-based prior authorization requests can lead to harmful delays in patient access to treatment and therapy drop-off.
CBI’s premier Real-Time Benefit Verification & ePrior Authorization Forum convenes key stakeholders to address these challenges and discuss the adoption of ePrior authorization (ePA) and other emerging electronic patient services/technologies to ultimately streamline patient access to medication.
Hear from manufacturers, payers, PBMs, prescribers, leading service providers and more on this evolving and critically important topic. Speakers come from such organizations as AssistRx, Avanir Pharmaceuticals, CoverMyMeds, Endo Pharmaceuticals, Express Scripts, Gilead Sciences, Lash Group, MedImmune, Medivation, Otsuka America Pharmaceutical, Pfizer, Point-of-Care Partners, Prime Therapeutics, Rhodes Pharmaceuticals, Sonexus Health, UBC, and more.
Register Today! Drug Channels subscribers will save $400 off of the standard registration rate when they use code YRK398.*
*Cannot be combined with other offers or used towards a current registration. Other restrictions may apply.
No comments:
Post a Comment